Litigation Details for OTSUKA PHARMACEUTICAL CO., LTD. v. WOCKHARDT BIO AG (D.N.J. 2014)
✉ Email this page to a colleague
OTSUKA PHARMACEUTICAL CO., LTD. v. WOCKHARDT BIO AG (D.N.J. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-03-28 |
| Court | District Court, D. New Jersey | Date Terminated | 2014-11-03 |
| Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | None | Referred To | Karen M. Williams |
| Patents | 8,017,615; 8,580,796 | ||
| Link to Docket | External link to docket | ||
Details for OTSUKA PHARMACEUTICAL CO., LTD. v. WOCKHARDT BIO AG (D.N.J. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-03-28 | 1 | infringement of U.S. Patent No. 8,0]?`,615 (“the ’615 patent”`) and U.S. Patent No. 8,580,796 ("‘the ’?…FOR PATENT INFRINGEMENT 13. The U.S. Patent and Trademark Office (‘“PTO”) issued thc ’61 5 patent on …’?96 patent”), arising under the United States patent laws, Title 35, United States Code, §lOO et seq.…of the `615 patent is attached as Exhibit A. l4. Otsuka is the owner ofthe "615 patent by virtue …he `615 patent expires on June 16._ 2024, and pediatric exclusivity relating to the ’615 patent expires | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
